{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:42:38Z","timestamp":1792172558195,"version":"4.4.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007471","name":"Applied Basic Research Foundation of Yunnan Province","doi-asserted-by":"publisher","award":["202101AY070001-050"],"award-info":[{"award-number":["202101AY070001-050"]}],"id":[{"id":"10.13039\/100007471","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007471","name":"Applied Basic Research Foundation of Yunnan Province","doi-asserted-by":"publisher","award":["2019FE001"],"award-info":[{"award-number":["2019FE001"]}],"id":[{"id":"10.13039\/100007471","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003996","name":"Kunming Medical University","doi-asserted-by":"publisher","award":["2024BS022"],"award-info":[{"award-number":["2024BS022"]}],"id":[{"id":"10.13039\/501100003996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011450","name":"Kunming Institute of Precious Metals State Key Laboratory of Advanced Technologies for Comprehensive Utilization of Platinum Metals","doi-asserted-by":"publisher","award":["2024XKTDPY20"],"award-info":[{"award-number":["2024XKTDPY20"]}],"id":[{"id":"10.13039\/501100011450","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.intimp.2025.114226","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T07:47:01Z","timestamp":1739519221000},"page":"114226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["IL17A\/F secreted by ASCT2-overexpression ovarian cancer cells contributes to immune escape through the suppression of natural killer (NK) cells cytotoxicity by the activation of c-JUN\/ PTGS2 pathway"],"prefix":"10.1016","volume":"150","author":[{"given":"Huixiang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haohan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Langping","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shipu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"#cr-split#-10.1016\/j.intimp.2025.114226_b0005.1","doi-asserted-by":"crossref","unstructured":"Rebecca L. Siegel, MPH, Mathieu Laversanne, ScIsabelle Soerjomataram, MD, MS, PhD, Ahmedin Jemal, DMV, PhD, Freddie Bray, BSc, MSc, PhD. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA: A Cancer J. Clin. 71 (3) (2021) 209-249. doi: 10.3322\/caac.21660.","DOI":"10.3322\/caac.21660"},{"key":"#cr-split#-10.1016\/j.intimp.2025.114226_b0005.2","doi-asserted-by":"crossref","unstructured":"Hyuna Sung, PhD, Jacques Ferlay, MSc, ME; Rebecca L. Siegel, MPH, Mathieu Laversanne, ScIsabelle Soerjomataram, MD, MS, PhD, Ahmedin Jemal, DMV, PhD, Freddie Bray, BSc, MSc, PhD. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA: A Cancer J. Clin. 71","DOI":"10.3322\/caac.21660"},{"key":"#cr-split#-10.1016\/j.intimp.2025.114226_b0005.3","doi-asserted-by":"crossref","unstructured":"(3) (2021) 209-249. doi: 10.3322\/caac.21660.","DOI":"10.3322\/caac.21660"},{"key":"10.1016\/j.intimp.2025.114226_b0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m3773","article-title":"Treatment of epithelial ovarian cancer","author":"Kuroki","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.intimp.2025.114226_b0015","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdx441","article-title":"Treatment of recurrent ovarian cancer","volume":"28","author":"Pignata","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.intimp.2025.114226_b0020","doi-asserted-by":"crossref","unstructured":"Susana Banerjee, Kathleen N Moore, Nicoletta Colombo, Giovanni Scambia, Byoung-Gie Kim, Ana Oaknin, Michael Friedlander, Alla Lisyanskaya, Anne Floquet, Alexandra Leary, Gabe S Sonke, Charlie Gourley, Amit Oza, Antonio Gonz\u00e1lez-Mart\u00edn, Carol Aghajanian, William H Bradley, Eileen Holmes, Elizabeth S Lowe, Paul DiSilvestro.Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1\/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial, Lancet Oncol. 22 (12) (2021) 1721\u20131731. doi: 10.1016\/s1470-2045(21)00531-3.","DOI":"10.1016\/S1470-2045(21)00531-3"},{"issue":"4","key":"10.1016\/j.intimp.2025.114226_b0025","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1111\/jcmm.14133","article-title":"PARP inhibitors in ovarian cancer: Sensitivity prediction and resistance mechanisms","volume":"23","author":"Jiang","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.intimp.2025.114226_b0030","doi-asserted-by":"crossref","unstructured":"Usha Menon, Aleksandra Gentry-Maharaj, Matthew Burnell, Naveena Singh, Andy Ryan, Chloe Karpinskyj, Giulia Carlino, Julie Taylor, Susan K. Massingham, Maria Raikou, Jatinderpal K. Kalsi, Robert Woolas, Ranjit Manchanda, Rupali Arora, Laura Casey,Anne Dawnay, Stephen Dobbs, Simon Leeson, Tim Mould, Mourad W. Seif, Aarti Sharma, Karin Williamson, Yiling Liu, Lesley Fallowfield, Alistair J. McGuire, Stuart Campbell, Steven J. Skates, Ian J. Jacobs, Mahesh Parmar, Ovarian cancer population screening and mortality after long-term follow-up in the UK collaborative trial of ovarian cancer screening (UKCTOCS): a randomised controlled trial, Gynecol. Oncol. (2021) 537\u2013538. doi: 10.1016\/S0140-6736(21):00731-5.","DOI":"10.1016\/S0140-6736(21)00731-5"},{"key":"10.1016\/j.intimp.2025.114226_b0035","doi-asserted-by":"crossref","unstructured":"Tong Fu, Lei\u2011Jie Dai, Song\u2011Yang Wu, Yi Xiao, Ding Ma1, Yi Zhou Jiang, Zhi\u2011Ming Shao, Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response, J. Hematol. Oncol. 14 (1) (2021) 14:98(01-25).doi: 10.1186\/s13045-021-01103-4.","DOI":"10.1186\/s13045-021-01103-4"},{"key":"10.1016\/j.intimp.2025.114226_b0040","doi-asserted-by":"crossref","unstructured":"Baci Denisa, Bosi Annalisa, Gallazzi Matteo, Rizzi Manuela, Noonan Douglas M. Poggi Alessandro, Bruno Antonino, Mortara Lorenzo, The ovarian cancer tumor immune microenvironment (TIME) as target for therapy: a focus on innate immunity cells as therapeutic effectors, Inte. J. Mole. Sci. 21 (9) (2020), 3125(01-24). doi: 10.3390\/ijms21093125.","DOI":"10.3390\/ijms21093125"},{"issue":"11","key":"10.1016\/j.intimp.2025.114226_b0045","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/s41556-022-01002-x","article-title":"Metabolic communication in the tumour\u2013immune microenvironment","volume":"24","author":"Kao","year":"2022","journal-title":"Nat. Cell Biol."},{"issue":"2","key":"10.1016\/j.intimp.2025.114226_b0050","first-page":"129","article-title":"Anti-CD39 and anti-CD73 antibodies A1 and 7G2 improve targeted therapy in ovarian cancer by blocking adenosine-dependent immune evasion","volume":"6","author":"H\u00e4usler","year":"2014","journal-title":"Orig. Article."},{"issue":"3","key":"10.1016\/j.intimp.2025.114226_b0055","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1365-2567.2007.02660.x","article-title":"Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125)","volume":"122","author":"Belisle","year":"2007","journal-title":"Immunology"},{"issue":"13","key":"10.1016\/j.intimp.2025.114226_b0060","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1200\/JCO.2005.03.9594","article-title":"Impact of immune parameters on long-term survival in metastatic renal cell carcinoma","volume":"24","author":"Frede","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.intimp.2025.114226_b0065","doi-asserted-by":"crossref","unstructured":"Santiago Coca, M.D., Javier Perez-Piqueras, M.D., David Martinez, M.D., Antonio Colmenarejo, M.D., Miguel A. Saez, M.D., Carmen Vallejo, M.D., Jose A. Martos, M.D. ,Manuel Moreno, M.D . The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma, CANCER (1997) 2320\u20132328.doi: 10.1002\/\uff08sici\uff091097-0142\uff0819970615\uff0979:12<2320::aid-cncr5>3.0.co;2 \u4eba.","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P"},{"issue":"4","key":"10.1016\/j.intimp.2025.114226_b0070","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.semcancer.2005.04.005","article-title":"Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime?","volume":"15","author":"Fuchs","year":"2005","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.intimp.2025.114226_b0075","doi-asserted-by":"crossref","unstructured":"Hongli Jiang, Ning Zhang, Tongzhong Tang, Feng Feng, Haopeng Sun, Wei Qu, Target the human alanine\/serine\/cysteine transporter 2(ASCT2): achievement and future for novel cancer therapy, Pharmacol. Res. 158 (2020) 104844(01-12).doi: 10.1016\/j.phrs.2020.104844.","DOI":"10.1016\/j.phrs.2020.104844"},{"key":"10.1016\/j.intimp.2025.114226_b0080","doi-asserted-by":"crossref","unstructured":"Wang Qian, A. Beaumont Kimberley, J. Otte Nicholas, Font Josep, G. Bailey Charles, van Geldermalsen Michelle, M. Sharp Danae, C. Tiffen Jessamy, M. Ryan Renae, Jormakka Mika, K. Haass Nikolas, E.J. Rasko John, Holst Jeff, Targeting glutamine transport to suppress melanoma cell growth, Int. J. Cancer 135 (5) (2014) 1060-1071.doi: 10.1002\/ijc.28749.","DOI":"10.1002\/ijc.28749"},{"key":"10.1016\/j.intimp.2025.114226_b0085","doi-asserted-by":"crossref","unstructured":"Hassanein Mohamed, Qian Jun, D. Hoeksema Megan, Wang Jing, Jacobovitz Marie, Ji Xiangming, T. Harris Fredrick, K. Harris Bradford, L. Boyd Kelli, Chen Heidi, Eisenberg Rosana, P. Massion Pierre, Targeting SLC1a5\u2010mediated glutamine dependence in non\u2010small cell lung cancer, Int. J. Cancer 137 (7) (2015) 1587\u20131597.doi: 10.1002\/ijc.29535.","DOI":"10.1002\/ijc.29535"},{"issue":"10","key":"10.1016\/j.intimp.2025.114226_b0090","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.21873\/anticanres.16634","article-title":"Q.miR-122-5p restrains pancreatic cancer cell growth and causes apoptosis by negatively regulating ASCT2","volume":"43","author":"Ping","year":"2023","journal-title":"Anticancer Res."},{"issue":"9","key":"10.1016\/j.intimp.2025.114226_b0095","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1016\/j.apsb.2022.03.014","article-title":"Inhibition of ASCT2 induces hepatic stellate cell senescence with modified proinflammatory secretome through an IL-1\u03b1\/NF-\u03baB feedback pathway to inhibit liver fibrosis","volume":"12","author":"Feixia","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.intimp.2025.114226_b0100","doi-asserted-by":"crossref","unstructured":"Huiming Guo, Yu Xu, Feng Wang, X. T. Zongwen Shen, H.W. Hong Qian, K. Wang, Clinical associations between ASCT2 and p\u2011mTOR in the pathogenesis and prognosis of epithelial ovarian cancer, Oncol. Rep. (2018) 3725\u20133733.doi: 10.3892\/or.2018.6729.","DOI":"10.3892\/or.2018.6729"},{"key":"10.1016\/j.intimp.2025.114226_b0105","doi-asserted-by":"crossref","unstructured":"Ni Juan, Dai Wumin, Liu Chun, Ling Yutian, Mou Hanzhou, A pan-cancer analysis of SLC1A5 in human cancers, Heliyon 9 (6) (2023) e17598(01-11). doi: 10.1016\/j.heliyon.2023.e17598.","DOI":"10.1016\/j.heliyon.2023.e17598"},{"issue":"4","key":"10.1016\/j.intimp.2025.114226_b0110","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.intimp.2025.114226_b0115","doi-asserted-by":"crossref","unstructured":"Vivian John, Rao Arjun Arkal, Nothaft Frank Austin, Ketchum Christopher, Armstrong Joel, Novak Adam, Pfeil Jacob, Narkizian Jake, D. Deran Alden., Musselman-Brown Audrey, Schmidt Hannes, Amstutz Peter, Craft Brian, Goldman Mary, Rosenbloom Kate, Cline Melissa, O'Connor Brian, Hanna Megan, Birger Chet, Kent W. James, A. Patterson David, D. Joseph Anthony, Zhu Jingchun, Zaranek Sasha, Getz Gad, Haussler David, Paten Benedict, Toil enables reproducible, open source, big biomedical data analyses, Nat. Biotechnol. 35 (4) (2017) 314\u2013316.doi: 10.1038\/nbt.3772.","DOI":"10.1038\/nbt.3772"},{"key":"10.1016\/j.intimp.2025.114226_b0120","article-title":"ssGSEA score-based Ras dependency indexes derived from gene expression data reveal potential Ras addiction mechanisms with possible clinical implications","volume":"10 (1)","author":"Yi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2025.114226_b0125","doi-asserted-by":"crossref","unstructured":"Szklarczyk Damian, L. Gable Annika, Lyon David, Junge Alexander, Wyder Stefan, Huerta-Cepas Jaime, Simonovic Milan, T. Doncheva Nadezhda, H. Morris John, Bork Peer, J. Jensen Lars, Mering Christian von, STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets, Nucl. Acids Res. 47 (D1) (2019) D607\u2013D613.doi: 10.1093\/nar\/gky1131.","DOI":"10.1093\/nar\/gky1131"},{"key":"10.1016\/j.intimp.2025.114226_b0130","doi-asserted-by":"crossref","unstructured":"Paul Shannon, Daniel Ramage, Owen Ozier, Nitin S. Baliga, Jonathan T. Wang, Daniel Ramage, Nada Amin, Benno Schwikowski, T. Ideker, Cytoscape: a software environment for integrated models of biomolecular interaction networks, Genome Res. 13 (11) (2003) 2498\u20132504. doi: 10.1101\/gr.1239303.","DOI":"10.1101\/gr.1239303"},{"issue":"24","key":"10.1016\/j.intimp.2025.114226_b0135","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1038\/onc.2015.381","article-title":"ASCT2\/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer","volume":"35","author":"van Geldermalsen","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2025.114226_b0140","doi-asserted-by":"crossref","unstructured":"L. Schulte Michael, Fu Allie, Zhao Ping, Li Jun, Geng Ling, T. Smith Shannon, Kondo Jumpei, J. Coffey Robert, O. Johnson Marc, C. Rathmell Jeffrey, T. Sharick Joe, C. Skala Melissa, A. Smith Jarrod, Berlin Jordan, Washington M. Kay, L. Nickels Michael, Manning H. Charles, Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models, Nat. Med. 24 (2) (2018) 194\u2013202. doi: 10.1038\/nm.4464.","DOI":"10.1038\/nm.4464"},{"key":"10.1016\/j.intimp.2025.114226_b0145","doi-asserted-by":"crossref","unstructured":"Pengbo, H. Liang, X.L. Yongqing, Z. Xiuyuan, L. Zhou, L. Yiming, Q. Hong, Identification of molecular pattern and prognostic risk model based on ligand-receptor pairs in liver cancer, Front. Immunol. 14 (2023) 1187108 (01-15).doi: 10.3389\/fimmu.2023.1187108.","DOI":"10.3389\/fimmu.2023.1187108"},{"key":"10.1016\/j.intimp.2025.114226_b0150","doi-asserted-by":"crossref","unstructured":"Curigliano, GiuseppeGyneco-oncological genomics and emerging biomarkers for cancer treatment with immune-checkpoint inhibitors, Semin. Cancer Biol. 52 (2018) 253\u2013258. doi: 10.1016\/j.semcancer.2018.05.004.","DOI":"10.1016\/j.semcancer.2018.05.004"},{"issue":"2","key":"10.1016\/j.intimp.2025.114226_b0155","doi-asserted-by":"crossref","first-page":"898","DOI":"10.4049\/jimmunol.174.2.898","article-title":"Human CD4+ effector memory T cells persisting in the microenvironment of lung cancer xenografts are activated by local delivery of IL-12 to proliferate, produce IFN-\u03b3, and eradicate tumor cells","volume":"174","author":"Broderick","year":"2005","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114226_b0160","article-title":"Natural killer cells in cancer biology and therapy","volume":"19","author":"Song-Yang","year":"2020","journal-title":"Mole. Cancer"},{"issue":"9","key":"10.1016\/j.intimp.2025.114226_b0165","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1172\/JCI129338","article-title":"Killers 2.0: NK cell therapies at the forefront of cancer control","volume":"129","author":"Hodgins","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2025.114226_b0170","doi-asserted-by":"crossref","unstructured":"Zhang Zhuo, Luo Lin, Xing Chuan, Chen Yu, Xu Peng, Li Mao, Zeng Ling, Li Chao, Ghosh Sadashib, Della Manna Deborah, Townes Tim, J. Britt William, Wajapeyee Narendra, P. Sleckman Barry, Chong Zechen, Leavenworth Jianmei Wu, S. Yang Eddy, RNF2 ablation reprograms the tumor-immune microenvironment and stimulates durable NK and CD4+ T-cell-dependent antitumor immunity, Nat. Cancer 2 (10) (2021) 1018-1038.doi: 10.1038\/s43018-021-00263-z.","DOI":"10.1038\/s43018-021-00263-z"},{"issue":"6468","key":"10.1016\/j.intimp.2025.114226_b0175","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1126\/science.aav2588","article-title":"Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion","volume":"366","author":"Leone","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.intimp.2025.114226_b0180","doi-asserted-by":"crossref","unstructured":"Yoo Hee Chan, Park Seung Joon, Nam Miso, Kang Juwon, Kim Kibum, Yeo Joo Hye, Kim Joon-Ki, Heo Yunkyung, Lee Hee Seung, Lee Myeong Youl, Lee Chang Woo, Kang Jong Soon, Kim Yun-Hee, Lee Jinu, Choi Junjeong, Hwang Geum-Sook, Bang Seungmin, Han Jung Min, A variant of SLC1A5 is a mitochondrial glutamine transporter for metabolic reprogramming in cancer cells, Cell Metab. 31 (2) (2020) 267-283.e12.doi: 10.1016\/j.cmet.2019.11.020.","DOI":"10.1016\/j.cmet.2019.11.020"},{"issue":"6","key":"10.1016\/j.intimp.2025.114226_b0185","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1182\/blood-2002-02-0350","article-title":"Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect","volume":"100","author":"Farag","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.intimp.2025.114226_b0190","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41571-020-0426-7","article-title":"Exploring the NK cell platform for cancer immunotherapy","volume":"18","author":"Myers","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.intimp.2025.114226_b0195","first-page":"397","article-title":"TNF-\u03b1 in cancer treatment:molecular insights, antitumor effects, and clinical utility","author":"van Horssen","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.intimp.2025.114226_b0200","doi-asserted-by":"crossref","unstructured":"D. Huihui, W. Gongfu, Y. Zhen, S. Huimin, W. Lu, Role of interferon-gamma (IFN-\u03b3) and IFN-\u03b3 receptor 1\/2 (IFN\u03b3R1\/2) in regulation of immunity, infection, and cancer development: IFN-\u03b3-dependent or independent pathway, Biomed. Pharmacother. 155 (2022) 113683(01-14). doi: 10.1016\/j.biopha.2022.113683.","DOI":"10.1016\/j.biopha.2022.113683"},{"key":"10.1016\/j.intimp.2025.114226_b0205","doi-asserted-by":"crossref","unstructured":"Guo Tingting, Yang Ye, Gao Mingju, Qu Yuan, Guo Xiaoxi, Liu Yuan, Cui Xiuming, Wang Chengxiao, Lepidium meyenii Walpers polysaccharide and its cationic derivative re-educate tumor-associated macrophages for synergistic tumor immunotherapy, Carbohydr. Polym. 250 (2020) 116904(01-12).doi: 10.1016\/j.carbpol.2020.116904.","DOI":"10.1016\/j.carbpol.2020.116904"},{"key":"10.1016\/j.intimp.2025.114226_b0210","doi-asserted-by":"crossref","unstructured":"S\u00e9bastien Viel, Antoine Mar\u00e7ais, Fernando Souza-Fonseca Guimaraes, Roisin Loftus, Jessica Rabilloud, Morgan Grau, Sophie Degouve, Sophia Djebali, Am\u00e9lien Sanlaville, Emily Charrier, Jacques Bienvenu, Julien C. Marie, Christophe Caux, Jacqueline Marvel, Liam Town, Nicholas D. Huntington, Laurent Bartholin, David Finlay, Mark J. Smyth, ThierryWalzerTGF-b inhibits the activation and functions of NK cells by repressing the mTOR pathway, RE SE Arch Article (2016) 415 ra19(01-14).doi: 10.1126\/scisignal.aad1884.","DOI":"10.1126\/scisignal.aad1884"},{"key":"10.1016\/j.intimp.2025.114226_b0215","doi-asserted-by":"crossref","unstructured":"Choi Seung Hee, Cho Hui Bang, Choi Jin-Ho, Kim Hye Jin, Jang Hye Jung, Cho Seohyun, Maeng Eunchong, Park Hail, Ryu Ki Seo, Park Keun-Hong, Park Kyung-Soon, Nano-chemical priming strategy to enhance TGF-\u03b2 resistance and anti-tumor activity of natural killer cells, J. Control. Release 367 (2024) 768\u2013778. doi: 10.1016\/j.jconrel.2024.02.008.","DOI":"10.1016\/j.jconrel.2024.02.008"},{"key":"10.1016\/j.intimp.2025.114226_b0220","doi-asserted-by":"crossref","unstructured":"S\u00e9bastien Viel, Antoine Mar\u00e7ais, Fernando Souza-Fonseca Guimaraes, Roisin Loftus, Jessica Rabilloud, Morgan Grau, Sophie Degouve, Sophia Djebali, Am\u00e9lien Sanlaville, Emily Charrier, Jacques Bienvenu, Julien C. Marie, Christophe Caux, Jacqueline Marvel, Liam Town, Nicholas D. Huntington, Laurent Bartholin, David Finlay, Mark J. Smyth, Thierry Walzer, TGF-b inhibits the activation and functions of NK cells by repressing the mTOR pathway, Sci. Signal. 415 (2016) ra19(01-14).doi: 10.1126\/scisignal.aad1884.","DOI":"10.1126\/scisignal.aad1884"},{"key":"10.1016\/j.intimp.2025.114226_b0225","doi-asserted-by":"crossref","unstructured":"Yang Li, Pang Yanli, L. Moses Harold, TGF-\u03b2 and immune cells: an important regulatory axis in the tumor microenvironment and progression, Trends Immunol. 31 (6) (2010) 220-227.doi: 10.1016\/j.it.2010.04.002.","DOI":"10.1016\/j.it.2010.04.002"},{"issue":"12","key":"10.1016\/j.intimp.2025.114226_b0230","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/s41590-019-0514-y","article-title":"IL-17 receptor\u2013based signaling and implications for disease","volume":"20","author":"Xiaoxia","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2025.114226_b0235","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrc818","article-title":"Fortuitous convergences: the beginnings of JUN","author":"Vogt","year":"2002","journal-title":"Nat. Rev."},{"key":"10.1016\/j.intimp.2025.114226_b0240","doi-asserted-by":"crossref","unstructured":"Martin Schreiber, Andrea Kolbus, Fabrice Piu, Axel Szabowski, Uta Mo\u00a8hle-Steinlein, Jianmin Tian, Michael Karin, Peter Angel, E.F. Wagner, Control of cell cycle progression by c-Jun is p53 dependent, GENES DEV. (1998) 60\u2013619. doi: 10.1101\/gad.13.5.607.","DOI":"10.1101\/gad.13.5.607"},{"key":"10.1016\/j.intimp.2025.114226_b0245","unstructured":"Luyuan Zhang, Sinan Sun, Yumin Wang, Zeng, Wei Xiong, Yongzhen Mo, Shanshan Zhang, Zhaoyang Zeng, Wei Xiong, Guiyuan Li, Hao Chen, Can Guo, Gossypol induces apoptosis of multiple myeloma cells through the JUN-JNK pathway, Orig. Article. (2019) 870-883. doi: www.ajcr.us \/ISSN:2156-6976\/ajcr0107968."},{"key":"10.1016\/j.intimp.2025.114226_b0250","doi-asserted-by":"crossref","unstructured":"Song Hyunkeun, Park Hyunjin, Kim Jiyoung, Park Gabin, Kim Yeong-Seok, Kim Sung Mok, Kim Daejin, Seo Su Kil, Lee Hyun-Kyung, Cho DaeHo, Hur Daeyoung, IDO metabolite produced by EBV-transformed B cells inhibits surface expression of NKG2D in NK cells via the c-Jun N-terminal kinase (JNK) pathway, Immunol. Lett. 136 (2) (2011) 187\u2013193. doi: 10.1016\/j.imlet.2011.01.009.","DOI":"10.1016\/j.imlet.2011.01.009"},{"key":"10.1016\/j.intimp.2025.114226_b0255","doi-asserted-by":"crossref","unstructured":"Karakaslar Emin Onur, Katiyar Neerja, Hasham Muneer, Youn Ahrim, Sharma Siddhartha, Chung Cheng\u2010han, Marches Radu, Korstanje Ron, Banchereau Jacques, Ucar Duygu, Transcriptional activation of Jun and Fos members of the AP\u20101 complex is a conserved signature of immune aging that contributes to inflammaging, Aging Cell. 22(4) (2023) 13792(01-17). doi: 10.1111\/acel.13792.","DOI":"10.1111\/acel.13792"},{"issue":"Supplement_5","key":"10.1016\/j.intimp.2025.114226_b0260","doi-asserted-by":"crossref","first-page":"S422","DOI":"10.1513\/AnnalsATS.201602-095AW","article-title":"Aging of the immune system. mechanisms and therapeutic targets","volume":"13","author":"Weyand","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.intimp.2025.114226_b0265","doi-asserted-by":"crossref","unstructured":"Tuanjie Li, Qi Zhang, Yuming Jiang, Jiang Yu, Yanfeng Hu, Tingyu Mou, Guihua Chen Guoxin Li, Gastric cancer cells inhibit natural killer cell proliferation and induce apoptosis via prostaglandin E2, OncoImmunology 5(2) (2015) e1069936-1-e1069936-12. doi: 10.1080\/2162402x.2015.1069936.","DOI":"10.1080\/2162402X.2015.1069936"},{"issue":"1","key":"10.1016\/j.intimp.2025.114226_b0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/dju345","article-title":"Aspirin and COX-2 inhibitor use in patients with stage III colon cancer","volume":"107","author":"Ng","year":"2015","journal-title":"JNCI J. Natl. Cancer Inst."},{"issue":"8","key":"10.1016\/j.intimp.2025.114226_b0275","first-page":"4059","article-title":"Cyclooxygenase-2 inhibition enhances proliferation of NKT cells derived from patients with laryngeal cancer","volume":"37","author":"Klatka","year":"2017","journal-title":"Anticancer Res"},{"issue":"8","key":"10.1016\/j.intimp.2025.114226_b0280","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1080\/15548627.2018.1476809","article-title":"Suppression of autophagy and HCK signaling promotes PTGS2high FCGR3\u2212 NK cell differentiation triggered by ectopic endometrial stromal cells","volume":"14","author":"Jie","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.intimp.2025.114226_b0285","doi-asserted-by":"crossref","unstructured":"Ma Xinrong, Holt Dawn, Kundu Namita, Reader Jocelyn, Goloubeva Olga, Take Yukinori, M. Fulton Amy, A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE2-mediated immunosuppression and inhibits breast cancer metastasis, OncoImmunology 2 (1) (2014) e22647(01-08). doi: 10.4161\/onci.22647.","DOI":"10.4161\/onci.22647"},{"key":"10.1016\/j.intimp.2025.114226_b0290","article-title":"Prostaglandin E2 secreted by thyroid cancer cells contributes to immune escape through the suppression of Natural Killer (NK) cell cytotoxicity and NK cell differentiation","volume":"9","author":"Arum","year":"2018","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2025.114226_b0295","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrd4596","article-title":"Big opportunities for small molecules in immuno-oncology","volume":"14","author":"Adams","year":"2015","journal-title":"Nat. Rev. Drug Disc."},{"issue":"1","key":"10.1016\/j.intimp.2025.114226_b0300","article-title":"The IL-17 family in diseases: from bench to bedside","volume":"8","author":"Longjie","year":"2023","journal-title":"Signal Transduct. Target. Therapy"},{"issue":"1","key":"10.1016\/j.intimp.2025.114226_b0305","article-title":"The role of interleukin-17 in tumor development and progression","volume":"217","author":"Junjie","year":"2020","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.114226_b0310","article-title":"IL-17-producing cells in tumor immunity: friends or foes?","volume":"20","author":"Da-Sol","year":"2020","journal-title":"Immune Network"},{"issue":"9","key":"10.1016\/j.intimp.2025.114226_b0315","doi-asserted-by":"crossref","first-page":"5969","DOI":"10.1074\/jbc.C600322200","article-title":"Chromatin remodeling of interleukin-17 (IL-17)-IL-17F cytokine gene locus during inflammatory helper T cell differentiation","volume":"282","author":"Akimzhanov","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.intimp.2025.114226_b0320","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s13402-020-00510-y","article-title":"IL-17A and IL-17F orchestrate macrophages to promote lung cancer","volume":"43","author":"Ferreira","year":"2020","journal-title":"Cell. Oncol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925002164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925002164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:58:21Z","timestamp":1778619501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925002164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":66,"alternative-id":["S1567576925002164"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114226","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL17A\/F secreted by ASCT2-overexpression ovarian cancer cells contributes to immune escape through the suppression of natural killer (NK) cells cytotoxicity by the activation of c-JUN\/ PTGS2 pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114226","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114226"}}